Page 2214 - Markets News

Indices post biggest jump in 7 weeks; RIL, HDFC bank top gainers

Recouping all the losses made in the previous session, the Nifty50 index rose 211.25 points, or 1.94 per cent, to end at 11,102

India Inc can now move Sebi to settle dispute with proxy advisory firms

The circular comes a day after Sebi issued the procedural guidelines

Oil rebounds with equities offsetting the return of Opec+ supply

The market is looking for its next clear signal, with a slew of mixed data pressuring it on either side

Domestic realty funds launch stressed funds to tap stalled projects

With very low sales and financing from banks and NBFCs drying up, fund managers expect good returns from their investments, experts said

Axis Bank sets a floor price of Rs 442.19 per equity share for QIP

Axis Bank on Tuesday said it has set a floor price of Rs 442.19 per equity share for its proposed Rs 15,000 crore qualified institutional placement (QIP).

Analysts cautious on road ahead for auto sector despite July sales recovery

For the auto sector as a whole, analysts now expect polarisation to get more entrenched where rural-focused plays like M&M, Escorts etc to do well

Sebi decides to decentralise portfolio managers registration work

Markets regulator Sebi on Tuesday said it has decided to decentralise work related to registration of portfolio managers.

Sebi bans 4 entities for providing unauthorised investment advice

Those facing ban are -- Money Increase, Venture Revenue, their proprietor Ashish Chourasiya and Shinal Jain, who is connected to Chourasiya

Change in assets under management, a near-term challenge for AMCs

In the current Covid-19 scenario, investors are more conservative with a rising preference for less risky liquid funds compared to equity

Margin pressures to cap upside for Dr Lal Pathlabs as Covid dents volumes

Valuations too do not leave much scope for gains

Securitisation volumes drop to Rs 7,500 crore in Q1FY21 due to pandemic

Lockdown impacted income generation capacity of many borrowers, making investors wary of fresh transactions given the likely deterioration in loan repaying capacity of retail borrowers

Market Wrap, August 4: Sensex gains 748 pts, Nifty at 11,095

Snapping its four-day losing streak, the domestic stock market ended around 2 per cent higher on Tuesday, led by buying in RIL, and HDFC Bank

India Inc can move Sebi over grievances against proxy advisors

Experts said move is expected to improve accountability at proxy advisory firms who have gained clout in influencing how minority shareholders vote on resolutions

Listed firms may come to resolve grievances against proxy advisors: Sebi

The regulator noted that proxy advisors, over the past few years, have played a key role in enabling shareholders to effectively participate in corporate governance decisions

RIL, HDFC Bank help indices end 4-day losing streak; Sensex gains 748 pts

All that happened in the markets today

Succession uncertainty over; HDFC Bank stk outperformance unlikely: Experts

The stock is, however, unlikely to outperform, say analysts, who feel the issues related to the moratorium induced across the financial sector due to Covid-19 pandemic will weigh on the sentiment

BPCL tumbles over 6% on report it's divestment may not happen in FY21

On July 29, the government had for the third time extended the deadline for bidding for privatisation of India's second-biggest oil refiner Bharat Petroleum Corp Ltd by two months to September 30

Dhanlaxmi Bank slides 5% as Q1 provisions jump 3-fold YoY to Rs 37 crore

The lender's provisioning for bad loans and contingenices spiked to Rs 37.02 crore in Q1FY21 as against Rs 9.27 crore a year ago. However, it was lower from previous quarter's Rs 56.89 crore

Domestic realty funds launch stressed funds to tap opportunities

When sales are very low and financing from banks and non banking finance companies are not coming, fund managers are expecting good returns from their investments, experts say

Jubilant Life slips 2.5% after scaling a 52-week peak in early trade

The company said it has launched the generic version of antiviral drug remdesivir in India.